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Abstract
Objective and design Cystic ﬁbrosis transmembrane
conductance regulator (CFTR) regulates infection and
inﬂammation. In this study, we investigated whether a lack
of functional CFTR in neutrophils would promote lipo-
polysaccharide (LPS)-induced lung inﬂammation and
injury.
Materials and methods CFTR-inhibited or F508del-
CFTR-mutated neutrophils were stimulated with LPS and
cultured to evaluate production of cytokines and NF-jB
activation. Wild-type mice were reconstituted with F508del
neutrophils or bone marrow and then intratracheally chal-
lenged with LPS to observe lung inﬂammatory response.
Results Pharmacologic inhibition and genetic mutation of
CFTR in neutrophils activated NF-jB and facilitated
macrophage inﬂammatory protein-2 (MIP-2) and tumor
necrosis factor-a (TNF-a) production. Wild-type mice
reconstituted with F508del neutrophils and bone marrow
had more severe lung inﬂammation and injury after LPS
challenge compared to wild-type mice receiving wild-type
neutrophils or bone marrow reconstitution.
Conclusions Lack of functional CFTR in neutrophils can
promote LPS-induced acute lung inﬂammation and injury.
Keywords Cystic ﬁbrosis transmembrane conductance
regulator  Neutrophils  Cytokine  Lipopolysaccharide 
Bone marrow transplantation
Introduction
There is evidence that an ion channel (sodium–potassium–
chloride cotransporter, NKCC1) can regulate the inﬂam-
matory response to lung infection and sepsis [1, 2]. There
are also studies indicating that another chloride channel,
cystic ﬁbrosis transmembrane conductance regulator
(CFTR), modulates proinﬂammatory responses [3, 4].
Mutation of CFTR can exaggerate lung inﬂammation
through increasing cytokine production and activating NF-
jB in lung epithelial cells [5, 6]. Inhibition of CFTR in
tracheal epithelial cells by CFTRinh-172 can also mimic
proinﬂammatory proﬁles [7]. CFTR may be a negative
regulator of NF-jB through which innate immune response
and inﬂammation is mediated [8].
It has been reported that CFTR can be expressed by
alveolar macrophages and neutrophils. Alveolar macro-
phages and neutrophils lacking functional CFTR are unable
to efﬁciently clear lung bacterial infection in cystic ﬁbrosis
[9, 10] and are more proinﬂammatory [11]. Bruscia et al.
[12] have further conﬁrmed that bone marrow-derived
macrophages (BMDM) and alveolar macrophages from
CFTR knockout mice can contribute to the elevated
cytokine production in response to LPS stimulation.
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123Comparison of cytokine production by blood neutrophils
from CF patients and from control subjects showed sig-
niﬁcantly increased IL-8 and decreased IL-1ra release by
CF neutrophils [13].
It is well-known that deﬁciency of CFTR leads to cystic
ﬁbrosis, which is primarily a chronic disease of large air-
ways that are frequently infected by Pseudomonas
aeruginosa [14]. Here, we should clarify that the purpose
of this study was focused on the modulatory role of CFTR
expressed by neutrophils in the sepsis-induced acute lung
inﬂammation and injury, since Gram-negative bacteria-
induced severe sepsis is a leading cause of acute lung
injury. Studies have showed that CFTR is expressed at
signiﬁcant levels in distal areas of the lung, both in small
airways (bronchioles) and in alveolar epithelial cells [15,
16] where acute lung inﬂammation and injury can develop
as a result of lung infections or sepsis [17]. CFTR is also
expressed in alveolar macrophages [9], which are native
immunoregulatory cells for alveolar infection. Neutrophils
are key players for sepsis-induced acute lung inﬂammation
and injury [17, 18]. In response to the challenge of endo-
toxin or bacteria, alveolar macrophages, and especially
neutrophils, can be activated leading to acute lung
inﬂammation and injury [17, 18].
Therefore, the objectives of this study were to test (1)
whether Escherichia coli endotoxin [lipopolysaccharide
(LPS)] stimulation affects CFTR expression in neutrophils;
(2) whether inhibition and mutation of CFTR in neutrophils
alters the activity of NF-jB and proinﬂammatory cytokine
production after LPS stimulation; (3) whether pharmaco-
logic inhibition or mutation of CFTR promotes LPS-
induced acute lung injury, and (4) whether neutrophils with
mutated CFTR are more proinﬂammatory than wild-type
neutrophils. Our overall objective was to test whether
CFTR expressed by neutrophils is a modulator of endo-
toxin-induced acute lung injury.
Materials and methods
Reagents
CFTRinh-172 (thiazolidinone CFTR inhibitor, 3-[(3-tri-
ﬂuoromethyl) phenyl]-5-[(4-carboxyphenyl) methylene]-2-
thioxo-4-thiazolidinone) was purchased from EMD Bio-
sciences (http://www.emdbiosciences.com)[ 7, 19]. MalH-2
(di-sulfonate glycine hydrazide, endotoxin free), a water
soluble CFTR inhibitor, was synthesized by A. Verkman’s
laboratory at the University California San Francisco
(UCSF) [20]. BMS-345541, an IKK-2 inhibitor was pur-
chased from Calbiochem (San Diego, CA). Rabbit anti-
CFTR polyclonal antibody (H-182) was from Santa Cruz
Biotechnology (Santa Cruz, CA).
Animals
Eight- to ten-week old CD1 wild-type and F508del-CF
mice were obtained from A. Verkman (UCSF) for these
studies. CFTR mutation nomenclature was in accordance
with CFTR Mutation HGVS Nomenclature stated on the
GeT-RM website (http://wwwn.cdc.gov/dls/genetics/
rmmaterials/default.aspx). Generation and genotyping
procedures of F508del-CF mice were described previously
[21, 22]. The F508del-CF mice were back-crossed into a
CD1 genetic background ([eight generations) and bred at
the UCSF animal facility. Anesthesia was induced with an
intraperitoneal injection (IP) of a mixture of ketamine
(90 mg/kg) and xylazine (10 mg/kg). The Committee on
Animal Research of the University of California, San
Francisco approved all the protocols.
LPS-induced acute lung injury mouse model
A previously developed direct visualization instillation
(DVI) method [23] was used to instill LPS (Sigma, E. coli
0111:B4, 5 mg/kg) into the airspaces of the lung. To test
the modulatory effects of CFTR in sepsis-induced acute
lung injury, LPS from E. coli instead of Pseudomonas
aeruginosa or its endotoxin (as a common pathogen for
cystic ﬁbrosis lung inﬂection) was used thorough the
experiments. The LPS dosage (5 mg/kg) was chosen aim-
ing to induce a robust lung inﬂammation and injury at 24 h
as previously reported [17, 24] and, at this dosage, no mice
died of intratracheal exposure of E. coli endotoxin.
Administration of CFTR inhibitor (MalH-2)
In the in vitro studies, 100 lM MalH-2 induced higher
proinﬂammatory responses in neutrophils than 20 lM
MalH-2, as reported previously in the epithelial cells [20].
In the in vivo studies, MalH-2 was given IP (dissolved in
PBS, 3 mg/kg) 20 min before intratracheal challenge with
LPS (5 mg/kg), and repeated again (3 mg/kg) 12 h later.
MalH-2 (2 mg/kg) was also administrated intratracheally
20 min before intratracheal challenge with LPS. The dos-
age of MalH-2 was selected as previously reported and
there were no detectable toxicity in cell cultures
(50–100 lM for 2 days) and in mice (4–8 mg/kg, twice
daily for 4 days) [20].
Measurement of extravascular lung water
At designated time points after LPS challenge, the mice
were euthanized by giving an IP injection of a mixture of
ketamine and xylazine and following by a cervical dislo-
cation. The gravimetric determination of extravascular
lung water has been described previously [18].
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123Measurements of lung myeloperoxidase activity
The activity of myeloperoxidase (MPO) was measured
using a kinetic assay using standard methods [24, 25].
Bronchoalveolar lavage, protein levels, neutrophil
count
We used standard methods as previously described [23, 24].
Neutrophil isolation and culture
The procedure of neutrophil isolation has been described
previously [26]. The isolated neutrophils were resuspended
in RPMI 1640 medium supplemented with 2 mM gluta-
mine, 100 U/ml penicillin, 100 lg/ml streptomycin, and
10% FCS (v/v). The ﬁnal concentration of neutrophils was
10
6/ml in 200 ll media. MalH-2 (100 lM) was added
30 min before LPS (30 lM, which induced a higher pro-
inﬂammatory cytokine production) stimulation. After 4 and
12 h, the supernatant was aspirated, centrifuged, and stored
at -70C.
Neutrophil depletion and reconstitution
Neutrophil depletion was accomplished with a rat, anti-
mouse monoclonal antibody (mAb) against the neutrophil
maturation antigen, Gr-1. The Gr-1 mAb was puriﬁed from
the RB6-8C5 hybridoma using standard methods. The Gr-1
mAb (160 lg) was given IP yielding greater than 90%
neutrophil depletion at 24 h (data not shown). Before
neutrophil-depleted mice were intratracheally challenged
with LPS (5 mg/kg), 6 9 10
6 freshly isolated bone marrow
neutrophils were injected intravenously to reconstitute
blood neutrophils as previously described [24, 26].
Bone marrow chimera experiments
As previously described, mice were lethally irradiated
(6 Gy) and immediately reconstituted via retro-orbital
injection with either WT or F508del bone marrow (5 9 10
6
cells) [27]. Mice were administered antibiotic-treated water
for 3 weeks and then used for experiments at approximately
8 weeks after bone marrow transfer. Using this protocol, at
8 weeks after bone marrow transplantation, more than 90%
of circulating hematopoietic cells are of donor origin.
Measurements of cytokine levels by ELISA
TNF-a, MIP-2, and IL-10 in the BAL, supernatant of
media, and plasma were measured by ELISA kits (TNF-a,
Endogen; MIP-2 and IL-10, R & D Systems, http://www.
rndsystems.com/).
Nuclear extraction and p65 NF-jB ELISA
Kits were purchased from Active Motif (Carlsbad, CA).
Nuclear extraction and measurement of p65 NF-jB were
performed according to the manufacturer’s instructions.
Detection of CFTR expression in neutrophils
by immunoﬂuorescence
We used standard methods for immunoﬂuorescence as we
have described previously [18]. The rabbit anti-CFTR
polyclonal antibody (H-182, Santa Cruz Biotechnology)
was used at a 1:200 dilution. The goat-anti-rabbit Cy3
labeled secondary antibody (Cy3, Sigma) were also used at
a 1:200 dilution.
Western blot for CFTR
Total cellular protein was extracted from neutrophils.
Fisher rat thyroid (FRT) cells expressing CFTR were used
as a positive control. Denatured protein samples were run
on a 4–12% gradient Bis-Tris gel (Invitrogen, Carlsbad,
CA), with 40 lg protein equal loading per lane, using a
MOPS SDS buffer (Invitrogen) at 100 V for 1.5 h. The
proteins were then transferred to a nitrocellulose membrane
and blocked with blocking buffer for 1 h. The membrane
was exposed to rabbit anti-CFTR polyclonal antibody
(H-182, Santa Cruz Biotechnology) at 1:100 dilution
overnight at 4C. The blot was washed and then exposed to
a HRP labeled antibody at 1:5,000 dilution for 45 min. The
protein bands were developed with an ECL kit (Amersham,
Piscataway, NJ). The optical density of bands was analyzed
using NIH image software.
Quantitative PCR
Gene expression in BAL cells and lung tissue was mea-
sured by a two-step multiplex RT-PCR method. Mouse
cytokine and CFTR primers and probes were designed with
‘‘Primer Express’’ software (Perkin Elmer, Foster City,
CA); primer sequences were as follows:
M-MCP-1-RTF TCTGGGCCTGCTGTTCACA
M-MCP-1-RTR CCAGCCTACTCATTGGGATCA
M-MCP-1-TMF GTTGGCTCAGCCAGATGCA
M-MCP-1-TMP CGCCCCACTCACCTGCTGCTACTC
M-MCP-1-TMR CCTACTCATTGGGATCATCTTGCT
M-MIP-2-RTF TCAAGAACATCCAGAGCTTGAGTG
M-MIP-2-RTR AACTTTTTGACCGCCCTTGAG
M-MIP-2-TMF AGTGTGACGCCCCCAGG
M-MIP-2-TMP CCCACTGCGCCCAGACAGAAGTCAT
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random hexamers, and the resulting cDNA product was
ampliﬁed using a mix of gene-speciﬁc primers and hot-start
PCR for 25 cycles. Transcript quantiﬁcations were run
along with -RT cDNA controls in a 384-well format on an
ABI Prizm 7900 Sequence Detection System (Applied
Biosystems, Foster City, CA). Data were collected as PCR
cycle threshold values for each gene and then converted to
relative gene copy numbers (GCN) based on linear
regression as previously described. Transcript copy was
normalized using a panel of ten housekeeping genes.
Statistical analysis
Statistics were done using SPSS software (SPSS, Chicago,
IL) and results are presented as mean ± SD. One-way
analysis of variance (ANOVA) with post hoc Bonferroni
test or Student’s t test were used as appropriate (level set at
P\0.05). Area under curve was calculated using Trape-
zoid Rule, Method 1.
Results
CFTR mRNA expression is upregulated in BAL
inﬂammatory cells from LPS-injured lungs
To study the effect of LPS-induced lung inﬂammation on
CFTR mRNA expression, we collected lung tissue and
BAL cells separately 24 h after wild-type mice were
challenged intratracheally with either PBS or LPS (5 mg/
kg). Histologically, LPS-injured lungs displayed pulmon-
ary edema, neutrophil inﬁltration, and hemorrhage (Fig. 1a,
b) and the mRNA of cytokines (MCP-1, MIP-2, IL-1b, and
TNF-a) increased 75, 1,029, 30, and 30-fold respectively
(Table 1). Gene transcripts of CFTR were detected, but
there was no difference between the PBS control and LPS-
challenged lung tissue (Table 1). In the BAL inﬂammatory
cells, LPS challenge switched the cell population from
alveolar macrophages to predominantly neutrophils
(Fig. 1c, d) and the mRNA of several cytokines (MCP-1,
MIP-2, IL-1b, and TNF-a) in the BAL cells increased, by
35, 494, 93, and 18.9-fold respectively (P\0.01,
Table 2). The mRNA for CFTR in the inﬂammatory cells
was elevated three-fold after LPS challenge (P\0.05,
Table 2). These data suggest that the acute inﬂamma-
tory cells (mainly neutrophils in the BAL) that respond to
Fig. 1 Histology of the lung and BAL inﬂammatory cells.
a, b Histology of normal (a) and lipopolysaccharide (LPS) injured
(b) lung (H-E staining, objective magniﬁcation 940, bar 50 lm).
c, d Percentage of alveolar macrophages and neutrophils in BAL cells
under normal conditions and LPS-induced acute lung injury (d)a t
24 h. MU Alveolar macrophages, N neutrophils
M-MIP-2-TMR TTTGACCGCCCTTGAGAGTG
M-IL-1b-RTF AGGCAGTATCACTCATTGTGGCT
M-IL-1b-RTR TGAGTCACAGAGGATGGGCTC
M-IL-1b-TMF AGAAGCTGTGGCAGCTACCTG
M-IL-1b-TMP TCTTTCCCGTGGACCTTCCAGGATG
M-IL-1b-TMR GGAAAAGAAGGTGCTCATGTCC
M-TNF-a-RTF TGCTCAGAGCTTTCAACAACTACTC
M-TNF-a-RTR GAGGCTCCAGTGAATTCGGA
M-TNF-a-TMF GGACAGTGACCTGGACTGTGG
M-TNF-a-TMP CCTCTCATGCACCACCATCAAGGACTC
M-TNF-a-TMR AGTGAATTCGGAAAGCCCATT
M-IFNc-RTF GCAACAGCAAGGCGAAAAAG
M-IFNc-RTR AAAATTCAAATAGTGCTGGCAGAA
M-IFNc-TMF AGCTCATCCGAGTGGTCCAC
M-IFNc-TMP AGCTGTTGCCGGAATCCAGCCTC
M-IFNc-TMR AGCAGCGACTCCTTTTCCG
M-IL-13-RTF TCGAAGTAGCCCACTTTATAACAAAA
M-IL-13-RTR GAAAATGAGTCCACAGCTGAGATG
M-IL-13-TMF ACTGCTCAGCTACACAAAGCAACT
M-IL-13-TMP TCGCCACGGCCCCTTCTAATGA
M-TGF-b1-RTF CACCTGCAAGACCATCGACAT
M-TGF-b1-RTR GGGACTGGCGAGCCTTAGTT
M-TGF-b1-TMF AAACGGAAGCGCATCGAA
M-TGF-b1-TMP CCATCCGTGGCCAGATCCTGTCC
M-TGF-b1-TMR GGGACTGGCGAGCCTTAGTT
M-CFTR-RTF CGACTCCCTTCAGGCACTTC
M-CFTR-RTR ATTTGCGTCCGAGGCTTGT
M-CFTR-TMF TATCTTCCAGCAGGCCATTAGC
M-CFTR-TMP TTCTTCCAGGGCCGCCACTCC
M-CFTR-TMR ATTTGCGTCCGAGGCTTGT
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123LPS-induced lung inﬂammation and injury are able to
upregulate CFTR transcripts.
CFTR protein expression is upregulated in neutrophils
under LPS stimulation
To study whether neutrophils express CFTR, we isolated
mouse bone marrow neutrophils. The purity of isolated
neutrophils was more than 92% [24, 26]. These bone-
marrow derived neutrophils express CFTR (Fig. 2a, b).
To study whether activated neutrophils express CFTR,
BAL cells were isolated 24 h after mice were challenged
intratracheally with LPS (5 mg/kg). Neutrophils comprised
84 ± 6% of the BAL cell population (Fig. 1d) and these
neutrophils were also positively stained by anti-CFTR
antibody (Fig. 2c, d). To test whether CFTR protein
expression in neutrophils would be altered upon LPS
challenge, we cultured bone marrow neutrophils and
stimulated them with either PBS or LPS (30 lM). After
24 h, an equal amount of protein from the cell lysates was
used for Western blot analysis. As a positive control, we
used FRT cells that express high amounts of CFTR with a
molecular weight 170 kDa to demonstrate the speciﬁcity of
the anti-CFTR antibody (H-182). LPS-stimulated neutro-
phils also displayed a more intense 170 kD band, and the
optical density of the band was increased compared to the
PBS-stimulated group (P\0.05, Fig. 2e).
Inhibition of CFTR in neutrophils with MalH-2
increases the production of NF-jB dependent
proinﬂammatory cytokines
To test whether inhibition of CFTR in neutrophils would
increase proinﬂammatory cytokine production, we cultured
isolated wild-type bone marrow neutrophils for 4 h and
measured two important pro-inﬂammatory cytokines/che-
mokines—TNF-a and MIP-2—in the medium supernatant.
In LPS-stimulated bone marrow neutrophils, both TNF-a
and MIP-2 production were increased, and inhibition of
CFTR with MalH-2 further increased TNF-a and MIP-2
production (Fig. 3a, b). At 12 h, MalH-2 signiﬁcantly
increased MIP-2 production in LPS-stimulated wild-type
neutrophils compared to LPS only (Fig. 3c). For conﬁr-
mation, we used F508del neutrophils as a positive control.
At 12 h, MIP-2 levels in F508del neutrophils stimulated
with LPS were increased by three-fold compared to the
wild-type neutrophils stimulated with LPS (Fig. 3c), sug-
gesting that CFTR is a modulator of proinﬂammatory
cytokines in bone marrow neutrophils. To investigate
whether CFTR inhibition induced excessive MIP-2
Table 1 Alterations of mRNA
expression of cytokines and
cystic ﬁbrosis transmembrane
conductance regulator (CFTR)
in normal versus LPS-injured
lung
Gene copy numbers (mean ± SD) P values Fold
Normal LPS-injured
MCP-1 20,092 ± 4,965 1,512,494 ± 233,280 0.0036 75
MIP-2 12,777 ± 2,692 13,151,494 ± 664,219 0.001 1,029
IL-1 b 268,455 ± 60,329 8,068,521 ± 2,334,069 7.35 9 10
5 30
TNF-a 16,061 ±8,063 484,725 ± 143,663 8.5 9 10
5 30
IFN-c 3,474 ± 1,736 9,277 ± 4,422 0.025 2.67
IL-13 1,252 ± 650 2,553 ± 1,124 0.055 2
TGF-b1 1,043,985 ± 72,726 847,249 ± 95,611 0.006 0.86
CFTR 276,351 ± 32,068 238,070 ± 55,057 0.21 0.81
Table 2 Alterations of mRNA expression of cytokines and CFTR in normal versus LPS-challenged BAL cells
Gene copy numbers (mean ± SD) P values Fold
Normal LPS-injured
MCP-1 3,560 ± 5,209 125,365 ± 61,329 0.00149 35
MIP-2 93,277 ± 14,194 46,077,687 ± 15,286,520 0.000304 494
IL-1 b 319,310 ± 125,384 29,646,533 ± 2,233,126 0.00209 93
TNF-a 90,512 ± 71,027 1,711,051 ± 150,834 1.99 9 10
9 19
IFN-c 304 3,628 ± 1,726 N/A 12
IL-13 101 ± 31 384 ± 333 0.30771 3.8
TGF-b1 2,063,179 ± 56,175 1,536,760 ± 163,824 0.000138 0.74
CFTR 1,006 ± 676 3,484 ± 1,809 0.04258 3
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123production in neutrophils through an NF-jB pathway, LPS
simulated wild-type neutrophils were pretreated either with
BMS-345541 (50 lM, which was chosen to reach maximal
inhibitory effects on NF-jB in neutrophils) or BMS-
345541 ? MalH-2. BMS-345541 pretreated neutrophils
stimulated with LPS produced less MIP-2 compared to LPS
alone. BMS-345541 also completely inhibited excessive
MIP-2 production in the LPS-stimulated neutrophils with
MalH-2 pretreatment (Fig. 3d), suggesting that CFTR
regulates MIP-2 production through the NF-jB pathway in
LPS-stimulated bone marrow neutrophils.
Lack of functional CFTR in neutrophils contributes
to inﬂammatory imbalance and promotes NF-jB
translocation
To study whether lack of functional CFTR in neutrophils
affects both pro- and anti-inﬂammatory cytokines, isolated
bone marrow neutrophils were pretreated with CFTRinh-
172 (5 lM), stimulated with LPS, and cultured for 12 h to
measure MIP-2 and IL-10 in the medium. The adherent
neutrophils were then harvested for measurement of p65
NF-jB subunit in nuclear extract; MIP-2 levels increased
more than two-fold (Fig. 4a) and IL-10 was signiﬁcantly
decreased (Fig. 4b) in the medium. The p65 NF-jB subunit
in the neutrophil nucleus extract with LPS plus CFTRinh-
172 inhibition was increased two-fold compared to LPS
only (Fig. 4c). To conﬁrm this result, F508del and wild-
type neutrophils were cultured and stimulated with LPS for
12 h to measure MIP-2 and IL-10 in the medium. The cells
were then harvested for measurement of p65 NF-jB in the
nucleus. MIP-2 levels were elevated three-fold (Fig. 4d)
and IL-10 was reduced (Fig. 4e). There was increased p65
NF-jB translocation to the nucleus in the F508del neu-
trophils stimulated with LPS compared to wild-type
neutrophils receiving LPS challenge (Fig. 4f).
Lack of functional CFTR increases lung vascular
permeability and promotes neutrophil chemotaxis
and NF-jB translocation in LPS-induced acute lung
injury
To test the effect of CFTR inhibition in the airspaces of the
lung in vivo, the CFTR inhibitor-MalH-2 (2 mg/kg) was
instilled intratracheally into the airspaces of the lung
20 min prior to LPS challenge (5 mg/kg) or PBS (control).
Four hours later, protein concentration in the BAL (an
index of lung vascular permeability) in the MalH-2 pre-
treated group was increased (Fig. 5a). MalH-2 alone did
not show any effects on the parameters that we measured
compared to vehicle (data not shown). There was a trend
for an elevation of leukocyte and neutrophil counts in the
BAL in the MalH-2 pretreated/LPS treated group at this
early 4 h time point (Fig. 5b, c). For conﬁrmation, wild-
type and F508del mice were challenged intratracheally
with LPS (5 mg/kg). Four hours later, BAL protein, leu-
kocyte and neutrophil counts in F508del mice were
increased compared to the wild-type mice (Fig. 5d–f).
Additionally, wild-type and F508del mice were challenged
intratracheally with LPS (5 mg/kg) and sacriﬁced at 1 and
4 h to collect BAL cells and to measure p65 NF-jB
activity. The p65 NF-jB subunit was increased in the
nuclei of F508del BAL inﬂammatory cells at 1 and 4 h
compared to the wild-type BAL cells (Fig. 5g, h).
Fig. 2 Detection of CFTR by immunoﬂuorescence and Western blot
in mouse BAL and bone marrow neutrophils. a, b CFTR immuno-
ﬂuorescence in naı ¨ve neutrophils and LPS-stimulated neutrophils.
a The 2nd antibody was labeled with Cy3 without primary antibody.
b The 2nd antibody was labeled with Cy3 with primary anti-CFTR
antibody. c, d Detection of CFTR in BAL cells. c The 2nd antibody
was labeled with Cy3 without primary antibody. d The 2nd antibody
was labeled with Cy3 with primary anti-CFTR antibody. Experiments
were repeated three times. e Western blot for CFTR in neutrophils
and optical density of bands. Lanes (left to right): 1 FRT cells, 2 bone-
marrow neutrophils with PBS, 3 bone-marrow neutrophils with LPS
stimulation. *P\0.05 for LPS-stimulated neutrophils versus PBS-
treated neutrophils; experiments were repeated twice
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123Fig. 3 Pharmacologic inhibition or mutation of CFTR neutrophils
affects proinﬂammatory cytokine production and NF-jB activation.
a, b Cytokine levels in the supernatant of cultured neutrophils at 4 h.
a TNF-a. b MIP-2. *P\0.05 for LPS vs LPS ? MalH-2;
**P\0.01 vs PBS or MalH-2 only. c MIP-2 levels in the supernatant
of cultured neutrophils stimulated with LPS at 12 h. **P\0.01 for
wild-type neutrophils receiving MalH-2 or F508del neutrophils
stimulated with LPS vs LPS only. d Effect of inhibition of NF-jB
on production of MIP-2 in wild-type neutrophils with CFTR
inhibition by MalH-2. **P\0.01 for LPS vs LPS ? MalH-2;
## P\0.01 for LPS vs LPS MalH-2 ? BMS-34553. N = 6–8 in
each group. Values are mean ± SD
Fig. 4 Pro- and anti-
inﬂammatory cytokines in
neutrophils balance is impaired
without functional CFTR.
a–c Production of MIP-2
(a) and interleukin-10 (b) and
NF-jB activation (c) in the
cultured bone-marrow derived
wild-type neutrophils pretreated
with CFTRinh-172 and then
stimulated with LPS at 12 h.
**P\0.01 for
LPS ? CFTRinh-172 vs LPS
only. d–f Production of MIP-2
(d) and interleukin-10 (e) and
NF-jB activation (f) in the
cultured bone-marrow derived
wild-type neutrophils and
F508del neutrophils simulated
with LPS at 12 h. *P\0.05,
**P\0.01 for wild-type
neutrophils receiving LPS vs
F508del neutrophils stimulated
with LPS. N = 6–8 in each
group. Values are mean ± SD
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123Inhibition of CFTR with systemic administration
of MalH-2 worsens LPS-induced acute lung injury
To test whether systemic administration of a CFTR
inhibitor would amplify pulmonary and systemic inﬂam-
matory responses to endotoxin challenge, mice received an
intratracheal instillation of LPS (5 mg/kg) after CFTR
inhibition with MalH-2 (3 mg/kg, every 12 h, ip; this
dosage of MalH-2 itself did not cause any toxicity to the
mice). The ﬁrst MalH-2 injection was given 20 min prior to
IT LPS or PBS (control). At 24 h, extravascular lung water
(an index of pulmonary edema) was increased in the MalH-
2 treated group (Fig. 6a). The mice receiving MalH-2 and
LPS developed systemic neutrophilia (higher neutrophil
counts in the blood) and hypothermia (a sign of the sys-
temic inﬂammatory response) (Fig. 6b, c). Lung and BAL
MIP-2 levels, and MPO (an index of neutrophil inﬁltration)
were increased in the LPS ? MalH-2 group at 24 h com-
pared to the LPS only group (Fig. 6d–f). At 48 h, MIP-2
levels and MPO activity in the supernatant of the liver
homogenate were also increased with CFTR inhibition
(Fig. 6g, h).
LPS-induced acute lung injury is ampliﬁed in F508del
mice
To determine if the lack of functional CFTR worsens acute
lung injury, wild-type and F508del mice were challenged
intratracheally with LPS (5 mg/kg). At 24 h, extravascular
lung water and BAL total protein were higher in the
F508del mice that received intratracheal LPS compared to
wild-type mice that received intratracheal LPS (Fig. 7a, b).
After LPS challenge in the F508del mice, there was more
neutrophil recruitment into the airspaces (Fig. 7c) and
more systemic neutrophilia (Fig. 7d). There was also an
ampliﬁed proinﬂammatory state in the lung (higher BAL
MIP-2 and TNF-a, Fig. 7e, f) and systemically (increased
plasma MIP-2 and TNF-a, Fig. 7g, h). Additionally, at
Fig. 5 In vivo effects of
intratracheal CFTR
pharmacologic inhibition in
mice challenged with LPS. a–
c MalH-2 inhibition at 4 h:
a BAL protein, b BAL
leukocytes, c BAL neutrophils;
N = 5 per group. d–f F508del
mice at 4 h: d BAL protein,
e BAL leukocytes, f BAL
neutrophils; N = 10 per group.
g, h p65 NF-jB activity in the
nucleus of BAL inﬂammatory
cells from wild-type and
F508del mice at 1 h (g) and 4 h
(h); N = 5 per group. Values
are mean ± SD
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12324 h, p65 NK-jB activity in the nucleus was greater in the
BAL inﬂammatory cells from F508del mice (Fig. 7i).
F508del bone marrow contributes to lung inﬂammation
and injury
To isolate the effects of CFTR dysfunction in vivo, we
created bone marrow chimeras using wild-type and
F508del mice. Two months after bone marrow transplan-
tation, WT/WT (wild-type mice receiving wild-type bone
marrow), WT/F508del (wild-type mice receiving F508del
bone marrow), F508del/WT (F508del mice receiving wild-
type bone marrow), and F508del/F508del mice (F508del
recipient receiving F508del bone marrow) were challenged
intratracheally with LPS. At 24 h after LPS, BAL MPO
and protein levels were elevated in all groups compared to
the WT/WT group (Fig. 8a–c). Higher MIP-2 production
was also found in the airspaces of the WT/F508del group
and F508del/F508del groups compared to the WT/WT
group (Fig. 8c).
F508del neutrophils contribute to lung inﬂammation
and injury
Since F508del bone marrow increases lung inﬂammation
and injury, we next conducted experiments on the speciﬁc
role of F508del neutrophils. We depleted neutrophils from
wild-type mice and replaced them with F508del neutro-
phils (6 9 10
6/mouse, IV), and then challenged these mice
with LPS (5 mg/kg) intratracheally. We also studied
neutrophil-depleted wild-type mice that received donor
wild-type neutrophils and neutrophil-depleted F508del
mice that received donor F508del neutrophils. At 4 h after
LPS challenge, BAL neutrophils were increased in neu-
trophil-depleted F508del mice that received donor F508del
neutrophils (Fig. 9a) compared to neutrophil-depleted
wild-type mice that received donor wild-type neutrophils,
which re-established the phenotype shown in Fig. 5f.
At 24 h, extravascular lung water was increased in neu-
trophil-depleted F508del mice that received donor F508del
neutrophils (Fig. 9d) compared to neutrophil-depleted
wild-type mice that received donor wild-type neutrophils,
which was also the phenotype of the mice in Fig. 7a. Most
importantly, reconstitution of neutrophil-depleted wild-
type mice with F508del neutrophils promoted neutrophil
recruitment into the airspaces of the lung, increased MIP-2
and TNF-a levels in the BAL (Fig. 9b, c) at 4 h, and
worsened extravascular lung water (Fig. 9d) compared to
neutrophil-depleted wild-type mice receiving wild-type
neutrophils at 24 h.
Discussion
Using both pharmacologic inhibition and mutation
(F508del) of CFTR, we provide evidence that lack of
functional CFTR in neutrophils propagates production of
NF-jB-dependent proinﬂammatory cytokines and worsens
LPS-induced acute lung inﬂammation and injury. We also
found that CFTR-mutated neutrophils are more
Fig. 6 CFTR pharmacologic
inhibition with MalH-2 worsens
LPS-induced acute lung injury
at 24 h. a Extravascular lung
water. b Blood neutrophils.
c Body temperature. d MIP-2
levels in the supernatant of lung
homogenate. e MPO activity in
the lung homogenate. f BAL
MIP-2 levels. g MIP-2 levels in
the supernatant of liver
homogenate. h MPO activity in
the liver homogenate.
*P\0.05 or **P\0.01 for
LPS ? MalH-2 vs LPS only.
N = 5–6, in each group. Values
are mean ± SD
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123inﬂammatory than wild-type neutrophils and amplify lung
inﬂammation and injury in response to LPS challenge.
IthasbeenreportedthathumanneutrophilsexpressCFTR
[10]. In this study, we also found that mouse neutrophils
expressedCFTRasconﬁrmedbyimmunoﬂuorescence,gene
transcript, and protein analysis. More importantly, for the
ﬁrsttime,wefoundthatCFTRexpressioninneutrophilswas
upregulated at the transcript and protein level after LPS
challenge.InaLPS-inducedacutelunginjurymousemodel,
CFTR expression in BAL cells (predominated by neutro-
phils)wasalsoincreasedbythreefold.Inhibitionormutation
of CFTR promotes NF-jB p65 translocation from the
cytoplasm to the nucleus in LPS-stimulated neutrophils,
suggesting that activation of CFTR might counteract NF-jB
activation and limit proinﬂammatory responses in the neu-
trophils. Lack of functional CFTR could result in excessive
NF-jB activation in neutrophils and therefore propagate a
hyper-inﬂammatory response.
Neutrophils can be mobilized from the bone marrow and
recruited into the airspaces of the lung after intratracheal
LPS challenge [28, 29]. If CFTR-deﬁcient neutrophils are
recruited into the lung, the proinﬂammatory state in
response to acute infection may be ampliﬁed [30, 31].
TNF-a and MIP-2 play important roles in mobilizing
neutrophils and promoting LPS-induced acute lung
inﬂammation [32, 33]. In the present study, inhibition and
mutation of CFTR facilitated production of proinﬂamma-
tory cytokines (TNF-a and MIP-2) in the BAL and
promoted neutrophil alveolar translocation and p65 NF-jB
translocation in the BAL cells (predominantly neutrophils).
Our results suggest that, under inhibition or mutation, the
inﬁltrated neutrophils in the airspaces of the lung can be
activated by LPS or bacterial challenge to produce more
NF-jB dependent proinﬂammatory cytokines and worsen
pulmonary inﬂammation. These results provide evidence to
support the hypothesis that the lack of functional CFTR in
neutrophils promotes proinﬂammatory responses, which
facilitate the development of sepsis-induced acute lung
inﬂammation and injury. In addition, lack of functional
CFTR in neutrophils also reduced production of the anti-
inﬂammatory cytokine, IL-10 [34], suggesting that CFTR
might also regulate the anti-inﬂammatory responses in
LPS-challenged neutrophils.
We also conducted experiments with neutrophil or bone
marrow reconstitution to conﬁrm that the lack of functional
CFTR in neutrophils promotes LPS-induced acute lung
inﬂammation and injury. Under LPS challenge, neutrophil-
depleted wild-type mice reconstituted with F508del
Fig. 7 Lack of functional CFTR worsens LPS-induced acute lung
injury in mice. a, b Extravascular lung water and BAL protein at 24 h
after wild-type and F508del mice were challenged intratracheally
with LPS; N = 5 per group, *P\0.05 or P\0.01 for F508del vs
wild-type mice. c, d Mutation of CFTR alters BAL neutrophil count,
and blood neutrophil counts at 24 h after intratracheal LPS; N = 5a t
0, 24 h in each group, *P\0.05 for F508del vs wild-type mice at
24 h. e, f Mutation of CFTR affect BAL MIP-2 and TNF-a at 24 h
between wild-type and F508del mice with intratracheal LPS: e BAL
MIP-2, f BAL TNF-a. g, h Effect of mutation of CFTR on plasma
MIP-2 and TNF-a at 24 h in wild-type and F508del mice with
intratracheal LPS. N = 5 at 0, 24 h in each group, *P\0.05 for
F508del vs wild-type mice at 24 h. i p65 NF-jB in the nuclei of BAL
inﬂammatory cells (including alveolar macrophages and neutrophils)
harvested from wild-type and F508del mice after intratracheal
instillation with LPS. N = 5 in each group, *P\0.05 for F508del
vs wild-type mice. Values are mean ± SD
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123neutrophils displayed higher BAL neutrophil counts, MIP-
2 and TNF-a, and severe pulmonary edema comparing
neutrophil-depleted wild-type mice reconstituted with
wildtype neutrophils. Wild-type mice reconstituted with
F508del bone marrow also demonstrated an elevated
alveolar neutrophil transmigration, vascular permeability,
and proinﬂammatory cytokine production (MIP-2) in
response to intratracheal endotoxin exposure. Taken toge-
ther, these ﬁndings also indicate that CFTR expressed by
neutrophils modulates proinﬂammatory responses during
LPS-induced acute lung inﬂammation and injury.
There is evidence that CF lung epithelia demonstrate a
constitutive upregulation of the pro-inﬂammatory chemo-
kine IL-8 and can increase IL-8 mRNA expression [35, 36]
with LPS stimulation in a NF-jB dependent mechanism
[5, 6, 10, 11]. We found that F508del mice reconstituted
with wild-type bone marrow exhibited higher BAL MPO
and protein levels but without an increase in BAL MIP-2
compared to wild-type recipients reconstituted with wild-
type bone marrow. The possible explanations include (1)
F508del lung epithelial cells are more permeable to wild-
type neutrophils; (2) F508del neutrophils are more potent
than the wild-type neutrophils to illicit MIP-2 production
by interacting with F508del macrophages or lung epithelial
cells; and (3) there may be inﬂammation-limiting factors
[37] in wild-type bone marrow to counteract the proin-
ﬂammatory responses in F508del mice after LPS challenge.
There has been a long standing debate as to whether
CFTR knockout or deltaF508 cells are more prone to
inﬂammatory injury in the presence or absence of infection
[38, 39]; however, in the present experiments, inhibition or
mutation of CFTR alone in neutrophils did not induce
proinﬂammatory responses, and this occurred only after
challenge with LPS, which also supports the hypothesis
that CFTR is a modulator for sepsis-induced acute lung
inﬂammation and injury.
Lung disease is the major cause of death in cystic
ﬁbrosis (CF). In a CFTR deﬁcient (cftrm
1HGU) mouse
model, capacity to clear Staphylococcus aureus and
Burkholderia (Pseudomonas) cepacia—two opportunistic
lung pathogens closely associated with lung disease in CF
subjects—was impaired. In response to repeated microbial
Fig. 8 Greater neutrophil
transmigration, higher epithelial
and vascular permeability, and
chemokine production in the
wild-type mice receiving
F508del bone marrow
transplantation and intratracheal
LPS challenge. a BAL
myeloperoxidase (MPO) using a
kinetic assay. *P\0.05 for
WT/WT vs WT/F508del,
F508del/WT, and F508del/
F508del group. b Comparison
of MPO levels in the BAL by
calculating area under curve to
conﬁrm the signiﬁcant
differences between WT/WT
and the other groups. c BAL
protein levels. P\0.05 or 0.01
for WT/WT vs WT/F508del,
F508del/WT, and F508del/
F508del group. d BAL MIP-2
levels. P\0.05 or 0.01 for WT/
WT vs WT/F508del, and
F508del/F508del group. Data
were pooled from at least three
independent experiments.
N = 4–6 in each group. Values
are mean ± SD
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1HGU mice developed severe pulmonary
edema, suggesting that lack of CFTR leads CF subjects to
be susceptible to lung diseases and hyper-inﬂammatory
responses [40].
Recently, Mckeon et al. [41] found that low levels of
CFTR mRNA could be identiﬁed in normal human neu-
trophils, but CFTR protein was not found in human
neutrophil lysates or immunoprecipitates. However, Painter
et al. [10] fond that CFTR was present exclusively in the
secretory vesicles of neutrophils. The CFTR chloride
channel was also detected in phagolysosomes—a special
organelle formed after phagocytosis. CFTR-mediated
halide transport in the phagosomes of human neutrophils
could be inhibited by thiazolidinone and glycine hydrazide
[42]. In our study, we found that mouse neutrophils express
CFTR under normal and LPS-stimulated conditions.
Thiazolidinone (CFTRinh-172) and glycine hydrazide
(MalH-2) CFTR inhibitors are able to inhibit CFTR
expressed both on the cell membrane and in intracellular
organelles because they are cell permeable [42, 43].
Although our ﬁndings may have relevance to CF
patients who develop acute Gram negative sepsis from
pneumonia or a non-pulmonary source, our ﬁndings do not
explain the recurrent infection and excessive inﬂammation
in CF airways [44, 45]. Further, another ion channel, such
as NKCC1 [1], might play an important role in modulating
inﬂammatory responses during sepsis-induced acute lung
inﬂammation and injury.
In summary, we provide new evidence that lack of
functional CFTR in neutrophils promotes production of
proinﬂammatory cytokines by activation of NF-jB, and
worsens LPS-induced acute lung inﬂammation and injury.
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Fig. 9 Neutrophil reconstitution experiments demonstrate that
F508del neutrophils are more proinﬂammatory in LPS-induced lung
injury model. a Reconstitution of wild-type mice with F508del
neutrophils promoted neutrophil recruitment into the airspaces of the
lung compared to wild-type mice that received wild-type neutrophils.
b, c Reconstitution of wild-type mice with F508del neutrophils
increased BAL MIP-2 and TNF-a levels compared to wild-type mice
that received wild-type neutrophils. d Reconstitution of wild-type
mice with F508del neutrophils worsened extravascular lung water
compared to wild-type mice that received wild-type neutrophils at
24 h. N = 5–8, in each group. P\0.05 or 0.01 for neutrophil-
depleted wild-type mice that received F508del neutrophils intrave-
nously vs neutrophil-depleted wild-type mice that received wild-type
neutrophils intravenously. Values are mean ± SD
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